Inversago Pharma Inc.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of INV-202 in Patients With Obesity and Metabolic Syndrome (NCT05891834) | Inversago Pharma Inc. | 2023-09-08 |
| Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease (NCT05514548) | Inversago Pharma Inc. | 2022-10-19 |
| A Study to Explore the PK and PD of INV-202 in Metabolic Syndrome (NCT05282446) | Inversago Pharma Inc. | 2022-03-01 |
| Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of INV-101 in Healthy Male and Female Subjects (NCT04531150) | Inversago Pharma Inc. | 2020-09-08 |
Track Inversago Pharma Inc. automatically
Every clearance here is in the API, with alerts when new ones post.